Market Closed -
London S.E.
07:36:55 01/07/2024 pm IST
|
After market
04:30:00 am
|
12
USD
|
-18.09%
|
|
11.24
|
-6.38%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46,232
|
32,946
|
43,898
|
30,301
|
21,849
|
9,720
|
-
|
-
|
Enterprise Value (EV)
1 |
62,045
|
48,668
|
51,685
|
39,503
|
30,172
|
17,104
|
16,467
|
15,475
|
P/E ratio
|
11.9
x
|
73.1
x
|
17.3
x
|
7
x
|
-7.09
x
|
-1.36
x
|
12.1
x
|
7.66
x
|
Yield
|
3.47%
|
4.92%
|
3.7%
|
5.45%
|
-
|
11.3%
|
8.88%
|
8.88%
|
Capitalization / Revenue
|
0.34
x
|
0.24
x
|
0.33
x
|
0.23
x
|
0.16
x
|
0.07
x
|
0.07
x
|
0.06
x
|
EV / Revenue
|
0.45
x
|
0.35
x
|
0.39
x
|
0.3
x
|
0.22
x
|
0.12
x
|
0.11
x
|
0.1
x
|
EV / EBITDA
|
7.37
x
|
6.82
x
|
7.87
x
|
6.3
x
|
6.03
x
|
3.86
x
|
3.96
x
|
3.21
x
|
EV / FCF
|
15.9
x
|
11.8
x
|
12.4
x
|
18.2
x
|
214
x
|
13.3
x
|
9.4
x
|
7.68
x
|
FCF Yield
|
6.27%
|
8.45%
|
8.08%
|
5.48%
|
0.47%
|
7.53%
|
10.6%
|
13%
|
Price to Book
|
1.95
x
|
1.59
x
|
1.84
x
|
1.03
x
|
0.77
x
|
0.68
x
|
0.68
x
|
0.62
x
|
Nbr of stocks (in thousands)
|
9,03,143
|
8,66,534
|
8,64,987
|
8,64,257
|
8,63,261
|
8,63,275
|
-
|
-
|
Reference price
2 |
51.19
|
38.02
|
50.75
|
35.06
|
25.31
|
11.26
|
11.26
|
11.26
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,36,866
|
1,39,537
|
1,32,509
|
1,32,703
|
1,39,081
|
1,45,646
|
1,47,859
|
1,50,669
|
EBITDA
1 |
8,413
|
7,138
|
6,567
|
6,268
|
5,002
|
4,430
|
4,156
|
4,826
|
EBIT
1 |
6,942
|
5,211
|
5,117
|
5,133
|
3,871
|
2,668
|
2,506
|
2,671
|
Operating Margin
|
5.07%
|
3.73%
|
3.86%
|
3.87%
|
2.78%
|
1.83%
|
1.69%
|
1.77%
|
Earnings before Tax (EBT)
1 |
4,527
|
743
|
1,995
|
3,985
|
-5,419
|
-13,328
|
460.1
|
1,282
|
Net income
1 |
3,982
|
456
|
2,542
|
4,337
|
-3,080
|
-6,937
|
770.4
|
1,180
|
Net margin
|
2.91%
|
0.33%
|
1.92%
|
3.27%
|
-2.21%
|
-4.76%
|
0.52%
|
0.78%
|
EPS
2 |
4.310
|
0.5200
|
2.930
|
5.010
|
-3.570
|
-8.301
|
0.9317
|
1.470
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,289
|
1,751
|
2,015
|
FCF margin
|
2.84%
|
2.95%
|
3.15%
|
1.63%
|
0.1%
|
0.88%
|
1.18%
|
1.34%
|
FCF Conversion (EBITDA)
|
46.26%
|
57.59%
|
63.59%
|
34.54%
|
2.82%
|
29.09%
|
42.14%
|
41.76%
|
FCF Conversion (Net income)
|
97.74%
|
901.54%
|
164.28%
|
49.92%
|
-
|
-
|
227.31%
|
170.71%
|
Dividend per Share
2 |
1.778
|
1.870
|
1.880
|
1.912
|
-
|
1.270
|
1.000
|
1.000
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
33,756
|
32,597
|
32,449
|
33,382
|
34,862
|
35,415
|
35,422
|
36,707
|
37,052
|
36,351
|
35,608
|
37,198
|
37,444
|
36,873
|
36,359
|
EBITDA
1 |
1,931
|
1,232
|
993
|
1,510
|
1,774
|
1,556
|
1,013
|
1,028
|
1,244
|
1,220
|
897.5
|
1,128
|
1,227
|
1,101
|
1,049
|
EBIT
1 |
1,657
|
955
|
744
|
1,014
|
1,215
|
959
|
683
|
687
|
900
|
613
|
433.7
|
579.1
|
717.1
|
603
|
505.9
|
Operating Margin
|
4.91%
|
2.93%
|
2.29%
|
3.04%
|
3.49%
|
2.71%
|
1.93%
|
1.87%
|
2.43%
|
1.69%
|
1.22%
|
1.56%
|
1.92%
|
1.64%
|
1.39%
|
Earnings before Tax (EBT)
1 |
947
|
-18
|
-758
|
-5,270
|
607
|
-382
|
-375
|
-358
|
-13,114
|
251
|
-51.81
|
178.5
|
356.6
|
91.45
|
35.53
|
Net income
1 |
883
|
289
|
-415
|
-3,721
|
703
|
118
|
-180
|
-67
|
-5,908
|
344
|
-6.973
|
151
|
290.7
|
127.7
|
70.6
|
Net margin
|
2.62%
|
0.89%
|
-1.28%
|
-11.15%
|
2.02%
|
0.33%
|
-0.51%
|
-0.18%
|
-15.95%
|
0.95%
|
-0.02%
|
0.41%
|
0.78%
|
0.35%
|
0.19%
|
EPS
2 |
1.020
|
0.3300
|
-0.4800
|
-4.310
|
0.8100
|
0.1400
|
-0.2100
|
-0.0800
|
-6.850
|
0.4000
|
-0.0519
|
0.1436
|
0.2831
|
0.1635
|
0.1100
|
Dividend per Share
2 |
0.4775
|
0.4775
|
0.4800
|
0.4800
|
-
|
0.4800
|
-
|
0.2500
|
0.2500
|
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
Announcement Date
|
31/03/22
|
30/06/22
|
13/10/22
|
05/01/23
|
28/03/23
|
27/06/23
|
12/10/23
|
04/01/24
|
28/03/24
|
27/06/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,813
|
15,722
|
7,787
|
9,202
|
8,323
|
7,384
|
6,746
|
5,755
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.88
x
|
2.203
x
|
1.186
x
|
1.468
x
|
1.664
x
|
1.667
x
|
1.623
x
|
1.193
x
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,289
|
1,751
|
2,015
|
ROE (net income / shareholders' equity)
|
22.3%
|
18.9%
|
20.5%
|
16.4%
|
11.9%
|
13.6%
|
17.2%
|
17.4%
|
ROA (Net income/ Total Assets)
|
5.87%
|
0.59%
|
5.46%
|
5.06%
|
3.68%
|
-8.93%
|
0.9%
|
1.35%
|
Assets
1 |
67,861
|
77,380
|
46,566
|
85,705
|
-83,627
|
77,708
|
85,596
|
87,435
|
Book Value Per Share
2 |
26.30
|
23.80
|
27.50
|
34.00
|
32.80
|
16.50
|
16.50
|
18.20
|
Cash Flow per Share
2 |
6.060
|
6.230
|
6.410
|
4.500
|
2.620
|
3.970
|
2.630
|
3.860
|
Capex
1 |
1,702
|
1,374
|
1,379
|
1,734
|
2,117
|
1,517
|
1,599
|
1,657
|
Capex / Sales
|
1.24%
|
0.98%
|
1.04%
|
1.31%
|
1.52%
|
1.04%
|
1.08%
|
1.1%
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Last Close Price
11.26
USD Average target price
14.12
USD Spread / Average Target +25.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -45.52% | 884.23Cr | | -24.76% | 663.08Cr | | -5.95% | 616.98Cr | | +91.60% | 499.93Cr | | -3.50% | 458.15Cr | | +1.56% | 440.09Cr | | -27.53% | 396.41Cr | | +2.28% | 284.79Cr | | -20.90% | 253.1Cr |
Other Drug Retailers
|